Immucell (ICCC) Share-based Compensation Growth (3y) (2013 - 2026)
Powered by 
Analysis
Immucell (ICCC) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 1.55% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 16.62% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -8.04% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -56.68% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | -17.13% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.13% |
| Sep 30, 2025 | 26.04% |
| Jun 30, 2025 | -6.31% |
| Mar 31, 2025 | 17.85% |
| Dec 31, 2024 | 18.94% |
| Sep 30, 2024 | 27.85% |
| Jun 30, 2024 | 24.52% |
| Mar 31, 2024 | 21.81% |
| Dec 31, 2023 | 21.08% |
| Sep 30, 2023 | 18.50% |
| Jun 30, 2023 | 18.39% |
| Mar 31, 2023 | 18.42% |
| Sep 30, 2022 | 14.47% |
| Jun 30, 2022 | 38.44% |
| Mar 31, 2022 | 4.78% |
| Dec 31, 2021 | -22.02% |
| Sep 30, 2021 | 36.57% |
| Jun 30, 2021 | 32.11% |
| Mar 31, 2021 | 47.61% |
| Dec 31, 2020 | 3.09% |